Indo-National Limited — Board Meeting, 04-02-2026: Outcome of Board Meeting

Indo National's board approved Q3 & 9M results. Q3 consolidated revenue was ₹106.31 Cr, with a net loss of ₹7.85 Cr. Key decisions include acquiring 46.76% of Medcuore for ₹5.69 Cr (now a subsidiary) and investing ₹8.50 Cr in Axial Aero CCPS. Amalgamation of Helios is progressing.